{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T22:10:09Z","timestamp":1750975809338,"version":"3.41.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.det.2025.03.007","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T03:31:17Z","timestamp":1747107077000},"page":"399-408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lesional Markers and Precursors of Melanoma"],"prefix":"10.1016","volume":"43","author":[{"given":"Valerie","family":"Foy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham H.","family":"Litchman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.det.2025.03.007_bib1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","article-title":"Global burden of cutaneous melanoma in 2020 and projections to 2040","volume":"158","author":"Arnold","year":"2022","journal-title":"JAMA Dermatol"},{"year":"2024","author":"Bolognia","series-title":"Dermatology: 2-Volume Set","key":"10.1016\/j.det.2025.03.007_bib3"},{"key":"10.1016\/j.det.2025.03.007_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejca.2021.04.029","article-title":"Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943-2036","volume":"152","author":"Garbe","year":"2021","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.det.2025.03.007_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv294","article-title":"Melanoma thickness and survival trends in the United States, 1989 to 2009","volume":"108","author":"Shaikh","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"21","key":"10.1016\/j.det.2025.03.007_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252111651","article-title":"Current insights into the role of UV radiation-induced oxidative stress in melanoma pathogenesis","volume":"25","author":"Gieniusz","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"20","key":"10.1016\/j.det.2025.03.007_bib8","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The genetic evolution of melanoma from precursor lesions","volume":"373","author":"Shain","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.det.2025.03.007_bib9","series-title":"Tumour site concordance and mechanisms of carcinogenesis","article-title":"Polycyclic aromatic hydrocarbons and associated occupational exposures","author":"Jameson","year":"2019"},{"issue":"2","key":"10.1016\/j.det.2025.03.007_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/jmg.2006.043802","article-title":"Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents","volume":"44","author":"Goldstein","year":"2007","journal-title":"J Med Genet"},{"issue":"4","key":"10.1016\/j.det.2025.03.007_bib11","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1158\/1055-9965.EPI-12-1346","article-title":"Dysplastic nevi and melanoma","volume":"22","author":"Goldstein","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.det.2025.03.007_bib12","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaad.2018.08.055","article-title":"Guidelines of care for the management of primary cutaneous melanoma","volume":"80","author":"Swetter","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"103288","key":"10.1016\/j.det.2025.03.007_bib13","article-title":"TERT promoter mutations and melanoma survival: a comprehensive literature review and meta-analysis","volume":"160","author":"Gandini","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.det.2025.03.007_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ccell.2018.06.005","article-title":"Genomic and transcriptomic analysis reveals incremental disruption of key signaling pathways during melanoma evolution","volume":"34","author":"Shain","year":"2018","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.det.2025.03.007_bib15","doi-asserted-by":"crossref","first-page":"a015388","DOI":"10.1101\/cshperspect.a015388","article-title":"Melanoma: clinical features and genomic insights","volume":"4","author":"Hawryluk","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"10.1016\/j.det.2025.03.007_bib16","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.3390\/ijms24043541","article-title":"The complex interplay between nevi and melanoma: risk factors and precursors","volume":"24","author":"Shreberk-Hassidim","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.det.2025.03.007_bib17","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bcp.2010.04.032","article-title":"Targeting KIT in melanoma: a paradigm of molecular medicine and targeted therapeutics","volume":"80","author":"Woodman","year":"2010","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.det.2025.03.007_bib18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.6004\/jnccn.2024.0036","article-title":"NCCN Guidelines\u00ae insights: melanoma: cutaneous, version 2.2024","volume":"22","author":"Swetter","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.det.2025.03.007_bib19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejca.2004.10.015","article-title":"Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.det.2025.03.007_bib20","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/archderm.139.3.282","article-title":"The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based estimate","volume":"139","author":"Tsao","year":"2003","journal-title":"Arch Dermatol"},{"author":"Navarro-Fernandez","key":"10.1016\/j.det.2025.03.007_bib21"},{"issue":"1","key":"10.1016\/j.det.2025.03.007_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2006.07218.x","article-title":"Melanoma risk in congenital melanocytic naevi: a systematic review","volume":"155","author":"Krengel","year":"2006","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2025.03.007_bib23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.det.2012.04.003","article-title":"Current management approaches for congenital melanocytic nevi","volume":"30","author":"Krengel","year":"2012","journal-title":"Dermatol Clin"},{"issue":"5","key":"10.1016\/j.det.2025.03.007_bib24","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/1523-1747.ep12374298","article-title":"Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the central malignant melanoma registry of the German Dermatological Society","volume":"102","author":"Garbe","year":"1994","journal-title":"J Invest Dermatol"},{"author":"Xiong","key":"10.1016\/j.det.2025.03.007_bib25"},{"issue":"4","key":"10.1016\/j.det.2025.03.007_bib26","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1365-2133.2010.10185.x","article-title":"Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis","volume":"164","author":"Lee","year":"2011","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2025.03.007_bib27","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0190-9622(95)90282-1","article-title":"Lentigo maligna and lentigo maligna melanoma","volume":"33","author":"Cohen","year":"1995","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2025.03.007_bib28","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1097\/PRS.0b013e3181bcf002","article-title":"Staged excision of lentigo maligna and lentigo maligna melanoma: a 10-year experience","volume":"124","author":"Bosbous","year":"2009","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"10.1016\/j.det.2025.03.007_bib29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.6004\/jnccn.2014.0066","article-title":"National comprehensive cancer network. Melanoma, version 4","volume":"12","author":"Coit","year":"2014","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.det.2025.03.007_bib30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/bjd.12611","article-title":"Radiotherapy for lentigo maligna: a literature review and recommendations for treatment","volume":"170","author":"Fogarty","year":"2014","journal-title":"Br J Dermatol"},{"issue":"24","key":"10.1016\/j.det.2025.03.007_bib31","doi-asserted-by":"crossref","first-page":"9583","DOI":"10.3390\/ijms21249583","article-title":"Melanoma biomarkers and their potential application for in vivo diagnostic imaging modalities","volume":"21","author":"Hessler","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.det.2025.03.007_bib32","first-page":"1845","article-title":"Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma","volume":"6","author":"Straume","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.det.2025.03.007_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.772165","article-title":"Predictive performance of serum S100B versus LDH in melanoma patients: a systematic review and meta-analysis","volume":"11","author":"Janka","year":"2021","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.det.2025.03.007_bib36","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/jamadermatol.2013.2466","article-title":"Dermoscopic evaluation of nodular melanoma","volume":"149","author":"Menzies","year":"2013","journal-title":"JAMA Dermatol"},{"unstructured":"CDKN2A mutations: cancer risk and management recommendations 2020. Simmons Comprehensive Cancer Center; 2020.","key":"10.1016\/j.det.2025.03.007_bib41"},{"key":"10.1016\/j.det.2025.03.007_bib43","series-title":"GeneReviews(\u00ae)","article-title":"BAP1 tumor predisposition syndrome","author":"Pilarski","year":"1993"},{"issue":"Suppl 1","key":"10.1016\/j.det.2025.03.007_bib44","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.21037\/tlcr.2019.11.24","article-title":"BAP1: role in carcinogenesis and clinical implications","volume":"9","author":"Kobrinski","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.det.2025.03.007_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.589929","article-title":"TERT-regulation and roles in cancer formation","volume":"11","author":"Dratwa","year":"2020","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.det.2025.03.007_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/genes15030355","article-title":"A POT1 founder variant associated with early onset recurrent melanoma and various solid malignancies","volume":"15","author":"Abu Shtaya","year":"2024","journal-title":"Genes (Basel)"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386352500021X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386352500021X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T21:44:29Z","timestamp":1750974269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073386352500021X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S073386352500021X"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2025.03.007","relation":{},"ISSN":["0733-8635"],"issn-type":[{"type":"print","value":"0733-8635"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lesional Markers and Precursors of Melanoma","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2025.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}